Skip to content

Clinical trials

Hepatoblastoma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatoblastoma Country / region: France Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20111
20141
20171
20201
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer1
Federation Francophone de Cancerologie Digestive1
GlaxoSmithKline1
Novartis Pharmaceuticals1
University Hospital, Strasbourg, France1
University of Birmingham1
University of Leicester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatoblastoma7
Carcinoma, Hepatocellular3
Rhabdomyosarcoma3
Liver Neoplasms2
Neuroblastoma2
Astrocytoma1
Cholangiocarcinoma1
Diffuse Intrinsic Pontine Glioma1
Disorders of Sex Development1
Ependymoma1

Trials

Showing 51 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.